NutraCea awarded diabetes patent in Mexico

By Elaine Rigoli

Tampa, Fla., June 13 - NutraCea announced Tuesday that its Mexican patent application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office.

The original patent application was previously approved in the United States and in Europe in 2001 by the U.S. Patent and Trademark Office under Patent No. 6303586 B1.

Additionally, the patent application has been approved in Korea by the Korean Intellectual Property office under Patent No. 10-2000-7002174.

The Mexican patent has been issued to the RiceX Co., a wholly owned subsidiary of NutraCea. The Mexican patent number is 232655.

The patent describes a treatment method for diabetes with 11 claims, including reducing glycosylated hemoglobin and improving synthesis of insulin in diabetic subjects by ingesting stabilized rice bran derivatives produced by NutraCea, according to a news release.

NutraCea, based in El Dorado Hills, Calif., develops proprietary product formulations, delivery systems and whole food nutrition products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.